RichardMSchwartzMD

PubMed

• 183 citations
  A proof of concept for structure-based vaccine design targeting RSV in humans.
  Michelle C. Crank, Tracy J. Ruckwardt, Man Chen, Kaitlyn M. Morabito, Emily Phung, Pamela Costner, LaSonji A. Holman, Somia P. Hickman, Nina M. Berkowitz, Ingelise J. ...> ;Science. 2019 Aug 2
• 4 citations
  Structural Characterization and Formulation Development of a Trivalent Equine Encephalitis Virus-Like Particle Vaccine Candidate.
  Vishal M. Toprani, Yuan Cheng, Newton Wahome, Harshit Khasa, Lisa A. Kueltzo, Richard M. Schwartz, C. Russell Middaugh, Sangeeta B. Joshi, David B. Volkin> ;Journal of Pharmaceutical Sciences. 2018 Jun 5
• Safety and Pharmacokinetics of the Fc-Modified HIV-1 Human Monoclonal Antibody VRC01LS: A Phase 1 Open-Label Clinical Trial in Healthy Adults
  Cynthia S Hendel, Grace L Chen, Julie E Ledgerwood, Richard M Schwartz, John R Mascola> ;PLoS One. 2018 Jan 25
• An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial.
  DeZure, A. D.,Coates, E. E.,Hu, Z.,Yamshchikov, G. V.,Zephir, K. L.,Enama, M. E.,Plummer, S. H.,Gordon, I. J.,Kaltovich, F.,Andrews, S.,McDermott, A.,Crank, M. C.,Koup...> ;NPJ Vaccines. 2017 Dec 22
• 200 citations
  Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults.
  Julie E. Ledgerwood, Emily E. Coates, Galina Yamshchikov, Jamie G. Saunders, LaSonji A. Holman, Mary E. Enama, Adam DeZure, Rebecca M. Lynch, Ingelise J. Gordon, Sarah...> ;Clinical and Experimental Immunology. 2015 Dec 1
• 18 citations
  Phase 1 study of pandemic H1 DNA vaccine in healthy adults.
  Michelle C. Crank, Ingelise J. Gordon, Galina Yamshchikov, Sandra Sitar, Zonghui Hu, Mary E. Enama, LaSonji A. Holman, Robert T. Bailer, Melissa B. Pearce, Richard A. ...> ;Plos One. 2015 Apr 17
• A Monovalent Chimpanzee Adenovirus Ebola Vaccine - Preliminary Report.
  Rampling, T.,Ewer, K.,Bowyer, G.,Wright, D.,Imoukhuede, E. B.,Payne, R.,Hartnell, F.,Gibani, M.,Bliss, C.,Minhinnick, A.,Wilkie, M.,Venkatraman, N.,Poulton, I.,Lella, ...> ;N. Engl. J. Med.. 2015 Jan 30
• 165 citations
  Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial
  Lee-Jah Chang, Kimberly A. Dowd, Floreliz Mendoza, Jamie G. Saunders, Sandra Sitar, Sarah H. Plummer, Galina Yamshchikov, Uzma N. Sarwar, Zonghui Hu, Mary E. Enama, Ro...> ;Lancet. 2014 Dec 6
• 19 citations
  Delivery of human immunodeficiency virus vaccine vectors to the intestine induces enhanced mucosal cellular immunity.
  Lingshu Wang, Cheng Cheng, Sung Youl Ko, Wing Pui Kong, Masaru Kanekiyo, David A. Einfeld, Richard M. Schwartz, C. Richter King, Jason G. D. Gall, Gary J. Nabel> ;Journal of Virology. 2009 Jul 15
• 1 citations
  Rapidly expanding lesion in a giant congenital melanocytic nevus.
  Nadia Masood Bajwa, Eliot N. Mostow, Richard M Schwartz> ;Clinical Pediatrics. 2003 Jun 1
• 9 citations
  Ultrasound appearance of a malignant fetal brain tumor
  Thomas H. Shawker, Richard M. Schwartz> ;Journal of Clinical Ultrasound. 1983 Jan 1
• 14 citations
  A study of familial male breast carcinoma and a second report.
  Richard M. Schwartz, Robert B. Newell, James F. Hauch, William H. Fairweather> ;Cancer. 1980 Dec 15
• The influence of extra-cellular matrix and stroma remodeling on the productivity of long-term human bone marrow cultures.
  Schwartz, R. M., Caldwell, J., Clarke, M. F., Emerson, S. G., Palsson, B. O.> ;Cytotechnology. 1992
• A serum-free Vero production platform for a chimeric virus vaccine candidate.
  Yuk, I. H., Lin, G. B., Ju, H., Sifi, I., Lam, Y., Cortez, A., Liebertz, D., Berry, J. M., Schwartz, R. M.> ;Cytotechnology. 2006 Jul 01
• Comparison of mussels and semi-permeable membrane devices as inter-tidal monitors of polycyclic aromatic hydrocarbons at oil spill sites (Boehm et al., 2005).
  Schwartz, R. M.> ;Mar Pollut Bull. 2006 Jan
• Join now to see all